Tia L Bush
CIK 1863418 · Chief Technology & Quality Ofc · last filed 2026-06-24
Tia L Bush is a Chief Technology & Quality Ofc who has filed 36 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for CNTA, was dated Jun 24, 2026. Across all open-market trades the lifetime net is −$4.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
36
-$4.64M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Technology & Quality Ofc | 3,000 | $40.50 | $121.5K | -$4.64M | 27 | 2026-06-24 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | Centessa Pharmaceuticals plc (CNTA) Delisted | Disp (D) | −147,954 | $0 | EDGAR |
| 2026-02-03 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | +26,451 | -$210.0K | EDGAR |
| 2025-11-18 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | — | -$743.2K | EDGAR |
| 2025-11-17 | — | Notice (144) | −40,000 | -$1.12M | EDGAR |
| 2025-11-13 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | — | -$663.2K | EDGAR |
| 2025-11-12 | — | Notice (144) | −40,000 | -$1.04M | EDGAR |
| 2025-09-24 | — | Notice (144) | −35,000 | -$840.0K | EDGAR |
| 2025-09-24 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | — | -$510.3K | EDGAR |
| 2025-09-11 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | — | -$611.8K | EDGAR |
| 2025-09-10 | — | Notice (144) | −25,000 | -$550.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.